Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032 von Ready, Neal, Farago, Anna F., de Braud, Filippo, Atmaca, Akin, Hellmann, Matthew D., Schneider, Jeffrey G., Spigel, David R., Moreno, Victor, Chau, Ian, Hann, Christine L., Eder, Joseph Paul, Steele, Nicola L., Pieters, Anne, Fairchild, Justin, Antonia, Scott J.

Volltext

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer von Rudin, Charles M, Reck, Martin, Johnson, Melissa L, Blackhall, Fiona, Hann, Christine L, Yang, James Chih-Hsin, Bailis, Julie M, Bebb, Gwyn, Goldrick, Amanda, Umejiego, John, Paz-Ares, Luis

Volltext

Pneumonitis in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors von Suresh, Karthik, Voong, Khinh Ranh, Shankar, Bairavi, Forde, Patrick M., Ettinger, David S., Marrone, Kristen A., Kelly, Ronan J., Hann, Christine L., Levy, Benjamin, Feliciano, Josephine L., Brahmer, Julie R., Feller-Kopman, David, Lerner, Andrew D., Lee, Hans, Yarmus, Lonny, D’Alessio, Franco, Hales, Russell K., Lin, Cheng Ting, Psoter, Kevin J., Danoff, Sonye K., Naidoo, Jarushka

Volltext

Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline von Rudin, Charles M, Ismaila, Nofisat, Hann, Christine L, Malhotra, Narinder, Movsas, Benjamin, Norris, Kim, Pietanza, M Catherine, Ramalingam, Suresh S, Turrisi, 3rd, Andrew T, Giaccone, Giuseppe

Volltext

Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort von Ready, Neal E., Ott, Patrick A., Hellmann, Matthew D., Zugazagoitia, Jon, Hann, Christine L., de Braud, Filippo, Antonia, Scott J., Ascierto, Paolo A., Moreno, Victor, Atmaca, Akin, Salvagni, Stefania, Taylor, Matthew, Amin, Asim, Camidge, D. Ross, Horn, Leora, Calvo, Emiliano, Li, Ang, Lin, Wen Hong, Callahan, Margaret K., Spigel, David R.

Volltext

A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC von Mohammad, Helai P., Smitheman, Kimberly N., Kamat, Chandrashekhar D., Soong, David, Federowicz, Kelly E., Van Aller, Glenn S., Schneck, Jess L., Carson, Jeffrey D., Liu, Yan, Butticello, Michael, Bonnette, William G., Gorman, Shelby A., Degenhardt, Yan, Bai, Yuchen, McCabe, Michael T., Pappalardi, Melissa B., Kasparec, Jiri, Tian, Xinrong, McNulty, Kenneth C., Rouse, Meagan, McDevitt, Patrick, Ho, Thau, Crouthamel, Michelle, Hart, Timothy K., Concha, Nestor O., McHugh, Charles F., Miller, William H., Dhanak, Dashyant, Tummino, Peter J., Carpenter, Christopher L., Johnson, Neil W., Hann, Christine L., Kruger, Ryan G.

Volltext

Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy von Suresh, Karthik, Psoter, Kevin J., Voong, Khinh Ranh, Shankar, Bairavi, Forde, Patrick M., Ettinger, David S., Marrone, Kristen A., Kelly, Ronan J., Hann, Christine L., Levy, Benjamin, Feliciano, Josephine L., Brahmer, Julie R., Feller-Kopman, David, Lerner, Andrew D., Lee, Hans, Yarmus, Lonny, Hales, Russell K., D’Alessio, Franco, Danoff, Sonye K., Naidoo, Jarushka

Volltext

Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors von GANDHI, Leena, CAMIDGE, D. Ross, DIVE, Caroline, ENSCHEDE, Sari H, NOLAN, Cathy, CHIU, Yi-Lin, BUSMAN, Todd, HAO XIONG, KRIVOSHIK, Andrew P, HUMERICKHOUSE, Rod, SHAPIRO, Geoffrey I, RUDIN, Charles M, DE OLIVEIRA, Moacyr Ribeiro, BONOMI, Philip, GANDARA, David, KHAIRA, Divis, HANN, Christine L, MCKEEGAN, Evelyn M, LITVINOVICH, Elizabeth, HEMKEN, Philip M

Volltext

Report of the First International Symposium on NUT Carcinoma von French, Christopher A, Cheng, Michael L, Hanna, Glenn J, DuBois, Steven G, Chau, Nicole G, Hann, Christine L, Storck, Simone, Salgia, Ravi, Trucco, Matteo, Tseng, Jennifer, Stathis, Anastasios, Piekarz, Richard, Lauer, Ulrich M, Massard, Christophe, Bennett, Kelly, Coker, Shodeinde, Tontsch-Grunt, Ulrike, Sos, Martin L, Liao, Sida, Wu, Catherine J, Polyak, Kornelia, Piha-Paul, Sarina A, Shapiro, Geoffrey I

Volltext

Selective Tropism of Seneca Valley Virus for Variant Subtype Small Cell Lung Cancer von POIRIER, J. T, DOBROMILSKAYA, Irina, MORIARTY, Whei F, PEACOCK, Craig D, HANN, Christine L, RUDIN, Charles M

Volltext

Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model von MacDiarmid, Jennifer A, Langova, Veronika, Bailey, Dale, Pattison, Scott T, Pattison, Stacey L, Christensen, Neil, Armstrong, Luke R, Brahmbhatt, Vatsala N, Smolarczyk, Katarzyna, Harrison, Matthew T, Costa, Marylia, Mugridge, Nancy B, Sedliarou, Ilya, Grimes, Nicholas A, Kiss, Debra L, Stillman, Bruce, Hann, Christine L, Gallia, Gary L, Graham, Robert M, Brahmbhatt, Himanshu

Volltext

A monoclonal antibody against KCNK9 K+ channel extracellular domain inhibits tumour growth and metastasis von Sun, Han, Luo, Liqun, Lal, Bachchu, Ma, Xinrong, Chen, Lieping, Hann, Christine L., Fulton, Amy M., Leahy, Daniel J., Laterra, John, Li, Min

Volltext

Phase 2 Study of Pemetrexed and Itraconazole as Second-Line Therapy for Metastatic Nonsquamous Non–Small-Cell Lung Cancer von Rudin, Charles M., Brahmer, Julie R., Juergens, Rosalyn A., Hann, Christine L., Ettinger, David S., Sebree, Rosa, Smith, Ruth, Aftab, Blake T., Huang, Peng, Liu, Jun O.

Volltext

Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors von Piha-Paul, Sarina A, Hann, Christine L, French, Christopher A, Cousin, Sophie, Braña, Irene, Cassier, Phillippe A, Moreno, Victor, de Bono, Johann S, Harward, Sara Duckworth, Ferron-Brady, Geraldine, Barbash, Olena, Wyce, Anastasia, Wu, Yuehui, Horner, Thierry, Annan, Meg, Parr, Nigel J, Prinjha, Rabinder K, Carpenter, Christopher L, Hilton, John, Hong, David S, Haas, Naomi B, Markowski, Mark C, Dhar, Arindam, O’Dwyer, Peter J, Shapiro, Geoffrey I

Volltext

Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma von Gallia, Gary L., Zhang, Ming, Ning, Yi, Haffner, Michael C., Batista, Denise, Binder, Zev A., Bishop, Justin A., Hann, Christine L., Hruban, Ralph H., Ishii, Masaru, Klein, Alison P., Reh, Douglas D., Rooper, Lisa M., Salmasi, Vafi, Tamargo, Rafael J., Wang, Qing, Williamson, Tara, Zhao, Tianna, Zou, Ying, Meeker, Alan K., Agrawal, Nishant, Vogelstein, Bert, Kinzler, Kenneth W., Papadopoulos, Nickolas, Bettegowda, Chetan

Volltext

Rapamycin Rescues ABT-737 Efficacy in Small Cell Lung Cancer von GARDNER, Eric E, CONNIS, Nick, POIRIER, John T, COPE, Leslie, DOBROMILSKAYA, Irina, GALLIA, Gary L, RUDIN, Charles M, HANN, Christine L

Volltext

Therapeutic Efficacy of ABT-737, a Selective Inhibitor of BCL-2, in Small Cell Lung Cancer von HANN, Christine L, DANIEL, Vincent C, RUDIN, Charles M, SUGAR, Elizabeth A, DOBROMILSKAYA, Irina, MURPHY, Sara C, COPE, Leslie, XUE LIN, HIERMAN, Jared S, WILBURN, Daniel L, WATKINS, D. Neil

Volltext

A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors von Mansfield, Aaron S., Hong, David S., Hann, Christine L., Farago, Anna F., Beltran, Himisha, Waqar, Saiama N., Hendifar, Andrew E., Anthony, Lowell B., Taylor, Matthew H., Bryce, Alan H., Tagawa, Scott T., Lewis, Karl, Niu, Jiaxin, Chung, Christine H., Cleary, James M., Rossi, Michael, Ludwig, Carrianne, Valenzuela, Ricardo, Luo, Yan, Aggarwal, Rahul

Volltext

Erlotinib inhibits growth of a patient-derived chordoma xenograft von Siu, I-Mei, Ruzevick, Jacob, Zhao, Qi, Connis, Nick, Jiao, Yuchen, Bettegowda, Chetan, Xia, Xuewei, Burger, Peter C, Hann, Christine L, Gallia, Gary L

Volltext

Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells von Gallia, Gary L, Tyler, Betty M, Hann, Christine L, Siu, I-Mei, Giranda, Vincent L, Vescovi, Angelo L, Brem, Henry, Riggins, Gregory J

Volltext